CodeBreaK 101 di ASCO 2025: Sotorasib Triplet di KRAS CRC – Oncodaily
CodeBreaK 101 di ASCO 2025: Terapi Tiga Kali Ganda Sotorasib untuk KRAS CRC (Oncodaily)
Kandungan penuh artikel
ASCO 2025: CodeBreaK 101 shows sotorasib triplet therapy offers durable responses in KRAS G12C-mutant metastatic colorectal cancer. , ASCO 2025 Annual Meeting, CodeBreaK 101 trial, colorectal cancer, KRASG12C
Produk Berkaitan Artikel Ini
Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.
Soalan Lazim
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Sotorasib – Beli dalam talian SOTOLDX Sotorasib 120mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.